Irvine, CA, United States of America

Anabel Haro

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Biosense Webster (Israel) Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anabel Haro. Retrieved from https://idiyas.com/inventor/anabel-haro

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anabel Haro: Innovator in Medical Technology

Introduction

Anabel Haro is a talented inventor based in Irwindale, California. She is currently associated with Biosense Webster, Inc., a company known for its advancements in medical technology. Although she has not yet registered any patents, her contributions to the field are noteworthy.

Latest Patents

As of now, Anabel Haro holds 1 patents. However, her work at Biosense Webster, Inc. indicates her potential for future innovations in medical devices and technologies.

Career Highlights

Anabel has made significant strides in her career at Biosense Webster, Inc. Her role involves working on cutting-edge technologies that aim to improve patient outcomes in the medical field. Her dedication and expertise are evident in her commitment to advancing medical solutions.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Anabel Haro is an emerging figure in the realm of medical technology, and her journey at Biosense Webster, Inc. is just beginning. Her future contributions may lead to significant advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…